ConductScience.org, home

Library / Genes

IL15: interleukin 15

1 protein, 906 patents, 1 drug, 7 trials, 12,269 NIH grants and 27,831 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolIL15HGNC
Nameinterleukin 15HGNC
NCBI Gene ID3600NCBI Gene
HGNC IDHGNC:5977HGNC
EnsemblENSG00000164136NCBI Gene
AliasesIL-15, MGC9721NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P40933Interleukin-151624Ensembl, GeneID, HGNCUniProt

Patents 906

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4810510 A22026-09-2331P40933Espacenet
EP 4806919 A12026-09-1620P40933Espacenet
WO 2026183237 A12026-09-03262P40933Espacenet
EP 4795154 A12026-08-26113P40933Espacenet
EP 4795155 A12026-08-2627P40933Espacenet
EP 4791437 A12026-08-19170P40933Espacenet
EP 4791785 A12026-08-193P40933Espacenet
EP 4774003 A12026-07-153P40933Espacenet
EP 4774398 A12026-07-1560P40933Espacenet
JP 2026520054 A2026-06-19131P40933Espacenet

Drugs 1

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ORDESEKIMABCHEMBL2109467Interleukin-15 inhibitorINHIBITORChEMBL

Trials 7

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT04424927ORDESEKIMABPHASE22025-10-20ClinicalTrials.gov
NCT04338581ORDESEKIMABPHASE22025-11-17ClinicalTrials.gov
NCT03439475ORDESEKIMABClinicalTrials.gov
NCT02637141ORDESEKIMABPHASE22019-12-03ClinicalTrials.gov
NCT02633020ORDESEKIMABPHASE22019-12-27ClinicalTrials.gov
NCT00443326ORDESEKIMABPHASE2ClinicalTrials.gov
NCT00433875ORDESEKIMABPHASE2ClinicalTrials.gov

NIH grants 12269

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant1802,025NIH's project files
P30CA016672Cancer Center Support Grant1382,025NIH's project files
P01CA065493Off-the-Shelf Immune Effector Cells for Hematological Malignancies1202,025NIH's project files
P01CA111412NK cells, their receptors and cancer therapy972,025NIH's project files
P30CA016058Cancer Center Support Grant672,025NIH's project files
P50CA126752SPORE in Lymphoma642,025NIH's project files
P30CA077598Cancer Center Support Grant532,025NIH's project files
P30CA021765Cancer Center Support Grant (CCSG)482,025NIH's project files
P30CA125123Baylor College of Medicine Cancer Center - Cancer Center Support Grant472,025NIH's project files
P30CA047904Cancer Center Support Grant462,025NIH's project files

Papers 27831

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42823731PubTator, text miningPubMed
42812769PubTator, text miningPubMed
42811027PubTator, text miningPubMed
42809553PubTator, text miningPubMed
42805341PubTator, text miningPubMed
42801536PubTator, text miningPubMed
42796874PubTator, text miningPubMed
42792724PubTator, text miningPubMed
42792683PubTator, text miningPubMed
42791438PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license